Rejected at 5:52 p.m. Sep, 28, 2023 ]
Author: MightyBooman
Related Note: 1477447267775 1
Rationale for change

Could we add a hint to both clozes to nudge us to think of respiratory disorders? Or perhaps change the note to only one cloze since both answers are related to respiratory. Hint could simply be "respiratory"?

Rejection reason

Ill make this change via Anki desktop. Thanks.

Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
Changed Tags
!NSU_KPCOM::M1::Winter2022::#Exam::Pharm&Immuno::Midterm !NSU_KPCOM::M1::Winter2022::#Exam::Pharm&Immuno::Final !NSU_KPCOM::M1::Winter2022::Pharmacology::Midterm::L14-15_AdrenergicAgonists !NSU_KPCOM::M1::Summer2022::Cardiovascular::Final::L50_PharmacologyOfIschemicHeartDisease
#AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::04_Beta_blockers #AK_Step1_v12::#Pixorize::03_Pharmacology::05_Alpha_&_Beta_Blockers::04_Beta-1_Selective_Blockers_(Atenolol,Esmolol,Metoprolol) #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::06_Class_II_Antiarrhythmics #AK_Step1_v12::#Pixorize::03_Pharmacology::05_Alpha_&_Beta_Blockers::05_Combined_Alpha-Beta_Blockers_(Carvedilol,Labetalol) #PANCE::EOR::IM #AK_Step1_v12::#UWorld::COMLEX::25109 #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::01_Cardiovascular_Pharmacology_I #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#AMBOSS::4Za3bQ #AK_Step1_v12::#B&B::06_Cardio::08_Hypertension::03_Antihypertensives_I #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Cardiology::Hypertension #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::02_Asthma::Extra #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step2_v12::#SketchyIM::01_Cardiology::06_Blood_Pressure::02_Hypertension_Management #AK_Step1_v12::#Pixorize::03_Pharmacology::24_Alpha_&_Beta_Blockers_(New)::09_Side_Effects_of_Beta_Blockers #AK_Step1_v12::#UWorld::Step::2000 #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::15_beta-blockers #AK_Step1_v12::#AMBOSS::f0ak2Q #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::01_Chronic_Asthma_SOA #AK_Step3_v12::#NBME::Form7::Section_2 #AK_Step1_v12::#AMBOSS::fNak0O #AK_Step1_v12::#Bootcamp::Pharmacology::04_Side_Effects_and_Toxins::02_Pharmacological_Toxicity_and_Treatment #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::10_Class_II_Antiarrhythmics #AK_Step1_v12::#Pixorize::03_Pharmacology::05_Alpha_&_Beta_Blockers::06_Non-selective_Beta-Blockers_(Propranolol,Timolol) #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::16_Beta_Adrenergic_Antagonists #AK_Step2_v12::#UWorld::Step::4742